| Patent Number |
Title Of Patent |
Date Issued |
| 7276341 |
Methods and reagents for diagnosis of autoantibodies |
October 2, 2007 |
| A number of octapeptides were generated from the sequences encoding the 60 kDa Ro/SSA peptide, the La/SSB autoantigen, the 70 kD nuclear ribonucleoprotein (nRNP), and the Sm B/B' polypeptide, which represent linear epitopes for autoantibodies present in the sera of SLE and SS patient |
| 7273613 |
Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders |
September 25, 2007 |
| Data consistent with autoimmune disease being caused by Epstein-Barr virus are shown. Based on this evidence, an effective vaccine would prevent the autoimmune disease in those vaccinated, modified or administered so that the vaccine is not itself capable of inducing autoimmune disease. |
| 7192715 |
Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
March 20, 2007 |
| Data consistent with autoimmune disease being caused by Epstein-Barr virus are shown. Based on this evidence, an effective vaccine would prevent the autoimmune disease in those vaccinated, modified or administered so that the vaccine is not itself capable of inducing autoimmune disease. |
| 7078173 |
Assays and therapies for latent viral infection |
July 18, 2006 |
| Compositions that bind viral proteins that are specifically expressed during the latent stage of the viral life cycle are disclosed. These compositions bind the latent viral proteins while the viral proteins are expressed in their cellular host, and provide a means for targeting cells |
| 6232522 |
Non-human animal model for systemic lupus erythematosis |
May 15, 2001 |
| A specific method has been developed to produce an autoimmune response and resulting clinical symptoms for a particular disease process. Peptides or other structures derived from an autoantigen and which are bound by auto antibody or T cell receptors are identified and used to induce an |
